N-Nitroso Valaciclovir Impurity C/N-Nitroso Valaciclovir USP Related Compound C ; N-Nitroso N-Methyl Valacyclovir
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.N-Nitroso Valaciclovir Impurity C is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Valaciclovir Impurity C CAS NO: NA chemically represented as 2-((2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)ethyl N-methyl-N-nitroso-L-valinate and it is also known as N-Nitroso Valaciclovir USP Related Compound C ; N-Nitroso N-Methyl Valacyclovir. Synchemia is the leading manufacturing and exporter of N-Nitroso Valaciclovir Impurity C .We supply N-Nitroso Valaciclovir Impurity C with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143889 |
| CAS No | NA |
| Mol.F. | C20H32N8O3S4 |
| Mol.Wt. | 560.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143890 |
| CAS No | NA |
| Mol.F. | C11H19N5O2S2 |
| Mol.Wt. | 317.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143891 |
| CAS No | NA |
| Mol.F. | C5H8N4O2S |
| Mol.Wt. | 188.21g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143892 |
| CAS No | NA |
| Mol.F. | C12H20N6O4S2 |
| Mol.Wt. | 376. 45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143893 |
| CAS No | NA |
| Mol.F. | C12H17N5O3S3 |
| Mol.Wt. | 375.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143894 |
| CAS No | NA |
| Mol.F. | C12H17D3N6O3S2 |
| Mol.Wt. | 363.47g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143895 |
| CAS No | NA |
| Mol.F. | C23H21D6ClN8O5S |
| Mol.Wt. | 569.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143896 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.11 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143897 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143898 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143899 |
| CAS No | NA |
| Mol.F. | C8H8N2O3S |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143900 |
| CAS No | NA |
| Mol.F. | C7H7BrN2OS |
| Mol.Wt. | 247.11 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143901 |
| CAS No | NA |
| Mol.F. | C9H11N3O3S |
| Mol.Wt. | 241.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143902 |
| CAS No | NA |
| Mol.F. | C14H24N6O7 |
| Mol.Wt. | 340.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143903 |
| CAS No | NA |
| Mol.F. | C14H25N3O5 |
| Mol.Wt. | 315.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143904 |
| CAS No | NA |
| Mol.F. | C15H27N3O7S |
| Mol.Wt. | 393.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |